Batchelor HK, Marriott JF Formulations for children: problems and solutions. Br J Clin Pharmacol. 2015; 79:(3)405-418

Coope H, Parviainen L, Withe M, Porter J, Ross RJ Hydrocortisone granules in capsules for opening (Alkindi) as replacement therapy in pediatric patients with adrenal insufficiency. Expert Opinion on Orphan Drugs. 2021; 9:(3)67-76

Khan D, Kirby D, Bryson S, Shah M, Rahman A Paediatric specific dosage forms: Patient and formulation considerations. Int J Pharm. 2022; 616

Mistry P, Batchelor H Evidence of acceptability of oral paediatric medicines: a review. J Pharm Pharmacol. 2017; 69:(4)361-376

Nunn T, Williams J Formulation of medicines for children. Br J Clin Pharmacol. 2005; 59:(6)674-676

Rashed AN, Terry D, Fox A, Christiansen N, Tomlin S Feasibility of developing children's Pill School within a UK hospital. Arch Dis Child. 2021; 106:(7)705-708

Roque F Paediatric Medicines: Formulation Considerations. Arch Pharma Pharma Sci. 2017; 1:024-027

Tse Y, Vasey N, Dua D, Oliver S, Emmet V, Pickering A, Lim A The KidzMed project: teaching children to swallow tablet medication. Arch Dis Child. 2020; 105:(11)1105-1107

A–Z of prescribing for children

02 March 2024
Volume 6 · Issue 3


This series focuses on aspects of prescribing for neonates, children and young people, from A–Z. Aspects of pharmacokinetics will be considered, alongside legal considerations, consent and medications in schools

There is a continuing need for pharmaceutical companies to manufacture age-appropriate medications for children. It is not just preferences for particular formulations that need to be considered, but also an appreciation of the physical and biochemical differences between children and adults (Batchelor and Marriott, 2015). ‘Paediatrics’ covers a wide age range, from neonates to adolescents, so their needs are also varied (Nunn and Williams, 2005). While it is understood that the oral route of drug administration is preferred for all ages, due to convenience and stability, many different forms can be considered. Oral liquids tend to be favoured in the lower age ranges, and can include many types (see Table 1). The volume of the oral liquid to be administered needs to be acceptable to the child; in children under the age of 4 years, the maximum recommended volume is 5 mL, where children between the ages of 4–12 years should not have doses exceeding 10 mL (Batchelor and Marriott, 2015).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month